SCENESSE® To Be Evaluated in Xeroderma Pigmentosum Variant (XPV) 2021 Announcements . Clinical . Corporate . Regulatory 24.03.2021
SCENESSE® Granted Market Access In Israel 2021 Announcements . Clinical . Corporate . Regulatory 11.02.2021
SCENESSE® DNA REPAIR STUDY IN HEALTHY VOLUNTEERS APPROVED 2020 Announcements . Clinical . Corporate 30.11.2020
Media Release – TGA approves Australian drug to protect patients from light and sun Clinical . News . Regulatory 27.10.2020
Media Release – First patient dosed in SCENESSE® DNA Repair Program Clinical . News . Regulatory 14.09.2020
Media Release (ASX) – CLINUVEL progresses innovative DNA Repair Program Clinical . News . Regulatory 10.09.2020
Media Release – New drug to repair damaged skin and reduce skin cancer risk Clinical . News . Regulatory 10.09.2020